Weight Loss And Obesity Management Market

Weight Loss and Obesity Management Market: Exponential Demand for Bariatric Surgery to Accelerate Revenue Generation: Global Industry Analysis 2013-2017 and Opportunity Assessment 2018-2028

  • 2019-02-27
  • REP-GB-411
  • 66 Tables
  • 119 Figures
  • 276 pages
  • PDF PPT EXCEL
Weight Loss And Obesity Management Market

An Incisive, In-depth Analysis on the Weight Loss And Obesity Management Market

This study offers a comprehensive, 360 degree analysis on the Weight Loss And Obesity Management market, bringing to fore insights that can help stakeholders identify the opportunities as well as challenges. It tracks the global Weight Loss And Obesity Management market across key regions, and offers in-depth commentary and accurate quantitative insights. The study also includes incisive competitive landscape analysis, and provides key recommendations to market players on winning imperatives and successful strategies.

Obesity management is an evolving area of focus, which has been witnessing an upsurge in demand, due to the increasing medical tourism in countries such as Thailand, India, Singapore, and Malaysia. Medical tourism is a growing sector for many middle-income countries as packages for countries such as India and Thailand cost low and constitute insurance coverage. The US and the UK have been the largest source countries for medical tourism to India for weight loss and obesity management.

According to research analysis, India was one of the most affordable medical tourism destinations as the country offers a wide variety of medical procedures at a low cost. Rising medical tourism for weight loss and obesity management in such countries provide immense opportunities for the weight loss and obesity management market players to launch products and increase geographical presence in emerging markets which would further contribute in driving the growth of the global weight loss and obesity management market.

New Product Launches for Weight Loss and Obesity Management Continue to Extend the Drug Pipeline

Various big pharmaceutical companies are developing novel anti-obesity drugs for weight loss and obesity management. Companies such as Sanofi, Novo Nordisk, AstraZeneca, Boehringer Ingelheim and others are expected to launch new drugs in the weight loss and obesity management market by 2026.

The current weight loss and obesity management market is rather sparse, comprising only few FDA approved drugs in the US and other markets. More recently, the FDA has approved four new drugs since 2012. Obesity is now the most investigated indication by the number of clinical trials. The obesity drugs pipeline consists of 94 trials across all stages of clinical development.  

Emergence of New Technologies and Therapies Assisting Market Growth

A number of electrical stimulation systems are being used for bariatric surgeries, which help in controlling hunger by electrically stimulating the nerves that control our hunger signals. One such recently approved system by the FDA is vBloc, which is a vagus nerve stimulator used to control hunger so that person feels full for some time. These devices can also be used to treat other diseases along with weight loss and obesity management.

Obesity has become a major concern worldwide as diet and exercise are inadequate for weight loss and obesity management. Sometimes targeted treatments must be combined with additional pharmacologic therapy drugs such as Contrave (naltrexone and bupropion), Empatic (bupropion and zonisamide) and Qsymia (phentermine and topiramate). Regulatory agencies worldwide have shown significant interest in combination treatments through recent approvals of multiple combinations. These approvals pave way for combination approaches of obesity treatment, which are expected to revolutionize the weight loss and obesity management market globally.

Side Effects of Drugs and Other Risks Associated with Weight Loss Surgeries to Prevail

It has been proven that bariatric surgery is more effective in terms of cost and treatment than other pharmaceutical interventions for weight loss and obesity management. However, this proven effectiveness is typically associated with certain risks that cannot be understated. Some of the major risks associated are excessive bleeding, infections, blood clots, low blood sugar, and malnutrition.

For instance, the contrave drug can cause serious side effects and eruption of suicidal thoughts in patients. Though the number of weight loss and obesity drug users is rapidly increasing, studies show that there are certain side effects and adverse health effects of these drugs over the long term. The side effects of drugs and risks associated with surgeries may hamper the growth of the weight loss and obesity management market during the forecast period.

Government Initiatives May Support Efforts to Tackle Obesity

A government serves numerous vital functions in a national public health crisis, including the childhood obesity epidemic. It provides leadership by responding to prevalent obesity as an urgent public health priority and coordinating the public and private sector response.

Some of the programmes initiated for weight loss and obesity management are Just Say Yes to Fruits and Vegetables Project (JSY), Special Supplemental Nutrition Program for Women, Infants, and Children (WIC), Eat Well Play Hard in Child Care Settings (EWPHCCS), Breastfeeding Friendly Child Care, Breastfeeding Friendly Practices Designation, Alaska Obesity Prevention & Control Program and others.

Despite government policy responses and greater individual responsibility, global obesity levels look set to keep rising. Government regulations and taxes might increase awareness of weight loss and obesity management and put pressure on food and beverage companies to reduce the calorific value of their products.

Competitive Landscape Analysis

The competition section of the weight loss and obesity management market report features profiles of key players operating in the weight loss and obesity management market based on their weight loss and obesity management market share, product offerings, and differential product marketing strategies.

A few key players featured in the weight loss and obesity management market report include Novo Nordisk A/S, GlaxoSmithKline plc., F. Hoffmann-La Roche AG, Allergan Plc, Johnson & Johnson Services, Inc, Medtronic plc., Vivus Inc., Eisai Co., Ltd., ReShape Lifesciences, Inc, Obalon Therapeutics, Aspire Bariatrics, Allurion Technologies Inc., Nalpropion Pharmaceuticals, Inc., and Beijing Noble Laser Technology Co., Ltd.

Definition

The weight loss and obesity management market covers devices and drugs used for managing or reducing weight in obese and overweight patients. Rising global burden of obesity and overweight is driving the need for preventive care. The global weight loss and obesity management market is analyzed by two segments namely product type and distribution sales.

About the Report

The report on the weight loss and obesity management market offers a comprehensive evaluation of the business opportunities in the weight loss and obesity management market along with insights on the weight loss and obesity management regulatory scenario for medical devices and drugs, pipeline assessment of drugs for weight loss and obesity management, potential of anti-obesity drugs in the market, pricing analysis, entry strategies, white space analysis, and list of key manufacturers in the weight loss and obesity management market for the duration from 2018 to 2026.

Segmentation

The report offers a comprehensive taxonomy of the weight loss and obesity management market on the basis of product type, distribution sales, and region. On the basis of product type, the global weight loss and obesity management market has been segmented into drugs and devices. On the basis of distribution sales, the global weight loss and obesity management market has been segmented into institutional sales and retail sales. From a geographical perspective, the weight loss and obesity management market has been segmented into North America, Latin America, Europe, South Asia, East Asia, Oceania, Middle East & Africa (MEA), and emerging countries like China, Brazil, and India.

Additional Questions Answered

Some of the additional questions addressed in this report on the weight loss and obesity management market-

  • What is the revenue potential of the weight loss and obesity management market across the regions of emerging economies?

  • Who are the key competitors in the weight loss and obesity management market and what are their portfolios?

  • What are the major challenges influencing the growth of the weight loss and obesity management market?

A recent market study published by the company – “Weight Loss and Obesity Management: Global Industry Analysis 2013 – 2017 and Forecast 2018 – 2028,” consists of a comprehensive assessment of the most important market dynamics. By conducting a thorough research on the historical as well as current growth parameters of the weight loss and obesity management market, the growth prospects of the market are obtained with maximum precision.

The report features unique and salient factors that may have a huge impact on the development of the weight loss and obesity management market during the forecast period. It can help the players to modify their manufacturing and marketing strategies to envisage maximum growth in the weight loss and obesity management in the upcoming years. The report provides detailed information about the current and future growth prospects of the weight loss and obesity management market in the most comprehensive way for better understanding of the readers.

Chapter 1 – Executive Summary

The report commences with the executive summary of the weight loss and obesity management market, which includes the summary of key findings and statistics of the market. It also includes the market value (US$ million) estimates of the leading segments of the weight loss and obesity management market.

Chapter 2 – Market Overview

Readers can find detailed taxonomy and the definition of the weight loss and obesity management market in this chapter, which helps understand the basic information about the weight loss and obesity management. This section also highlights the inclusions and exclusions, which helps the reader understand the scope of the weight loss and obesity management market report.

Chapter 3 – Key Success Factors

This chapter highlights the key success factors of the weight loss and obesity management market report, which include regulatory scenario for medical devices and drugs, pipeline assessment of drugs for obesity, potential of anti-obesity drugs in the market, entry strategies, white space analysis, and list of key manufacturers. The key regulations section of this chapter highlights the FDA and EMA regulatory processes for the approval of drugs and devices.

Chapter 4 – Global Weight Loss and Obesity Management Market - Pricing Analysis

This section highlights the average price of laser assisted liposuction devices, radio frequency assisted liposuction devices, ultrasound assisted liposuction devices, bariatric stapling devices, gastric band, gastric balloon systems, gastric emptying systems, and gastric electrical stimulation systems in the different region throughout the globe. The pricing benchmark for manufacturer level pricing and distributor level pricing is analysed in this section.

Chapter 5 – Global Weight Loss and Obesity Management Market Demand (in Value or Size in US$ Mn) Analysis 2013-2017 and Forecast, 2018-2028

This section explain the global market value analysis and forecast for the weight loss and obesity management market between the forecast periods of 2013-2028 is highlights in this section.

Chapter 6 – Market Background

This chapter explains the key macro-economic factors that are expected to influence the growth of the weight loss and obesity management market over the forecast period. Along with macroeconomic factors, this section also highlights the opportunity analysis for the weight loss and obesity management market. This chapter also highlights the key market dynamics of the weight loss and obesity management market, which include the drivers, restraints and trends. Moreover, readers will understand the key trends followed by the leading manufacturers in the weight loss and obesity management market.

Chapter 7 – Global Weight Loss and Obesity Management Market Analysis 2013-2017 and Forecast 2018-2028, By Product Type

Based on the product type, the weight loss and obesity management market is segmented into drugs and devices. The drugs segment is further segmented into GLP-1 receptor agonists, lipase inhibitors, serotonin receptor agonist, combination drug, and others. The devices segment is further segmented into liposuction devices, bariatric stapling devices, gastric band, gastric balloon systems, gastric emptying systems, and gastric electrical stimulation systems. In this chapter, readers can find information about the key trends and developments in the weight loss and obesity management market and market attractive analysis based on the type of products.

Chapter 8 – Global Weight Loss and Obesity Management Market Analysis 2013-2017 and Forecast 2018-2028, By Distribution Sales

Based on the distribution sales, the weight loss and obesity management market is segmented into institutional sales and retail sales. Intuitional sales is further segmented into Hospitals, Weightloss Clinics, and Ambulatory Surgery Centers. Retail sales is segmented into retail pharmacies, drug stores, and online sales.  In this chapter, the readers can find information about the key trends and developments in the weight loss and obesity management market and market attractive analysis based on distribution sales.

Chapter 9 – Global Weight Loss and Obesity Management Market Analysis 2013-2017 and Forecast 2018-2028, By Region

This chapter explains how the weight loss and obesity management market will grow across various geographic regions, such as North America, Latin America, Europe, South Asia, East Asia, Oceania, Middle East & Africa (MEA), and emerging countries.

Chapter 10 – North America Weight Loss and Obesity Management Market Analysis 2013-2017 and Forecast 2018-2028

This chapter includes a detailed analysis of the growth of the North America weight loss and obesity management market along with a country-wise assessment including the U.S. and Canada. Readers can also find market growth based on product type, distribution sales, and country for the weight loss and obesity management market in North America.

Chapter 11 – Latin America Weight Loss and Obesity Management Market Analysis 2013-2017 and Forecast 2018-2028

This chapter contains a snapshot of the Latin America weight loss and obesity management market. It includes the growth prospects of the weight loss and obesity management market in the leading LATAM countries such as Brazil, Mexico, and the rest of the Latin America region.

Chapter 12 – Europe Weight Loss and Obesity Management Market Analysis 2013-2017 and Forecast 2018-2028

The important growth prospects of the weight loss and obesity management market based on its product type, and distribution sales in several European countries, such as the U.K., Germany, France, Italy Spain, Russia and the rest of Europe, is included in this chapter.

Chapter 13 – South Asia Weight Loss and Obesity Management Market Analysis 2013-2017 and Forecast 2018-2028

India, Indonesia, Thailand , Malaysia are the leading countries in the South Asia region that are the prime subjects of assessment to obtain the growth prospects of the South Asia weight loss and obesity management market in this chapter. Readers can find detailed information about the growth parameters of the South Asia weight loss and obesity management market during the period 2018-2028.

Chapter 14 – East Asia Weight Loss and Obesity Management Market Analysis 2013-2017 and Forecast 2018-2028

This chapter highlights the growth of the weight loss and obesity management market in the East Asia by focusing on China, Japan and South Korea. This section also helps readers understand the key factors that are responsible for the growth of the weight loss and obesity management market in East Asia.

Chapter 15 – Oceania Weight Loss and Obesity Management Market Analysis 2013-2017 and Forecast 2018-2028

Readers can find important factors that can significantly impact the growth of the weight loss and obesity management market in Australia and New Zealand during the forecast period based on the market segmentation.

Chapter 16 – Middle East and Africa Weight Loss and Obesity Management Market Analysis 2013-2017 and Forecast 2018-2028

This chapter provides information about the growth of the weight loss and obesity management market in the major countries of the MEA region, such as GCC Countries, Turkey and South Africa, during the period 2018-2028.

Chapter 17 – Emerging Countries Weight Loss and Obesity Management Market Analysis 2013-2017 and Forecast 2018-2028

Readers can find important factors that can significantly impact the growth of the weight loss and obesity management market in emerging countries like China, India, and Brazil during the forecast period based on the market segmentation.

Chapter 18 – Competition Landscape

In this chapter, readers can find a comprehensive list of all the leading manufacturers in the weight loss and obesity management market, along with detailed information about each company, which includes the company overview, revenue shares, strategic overview, and recent company developments. Some of the players featured in the weight loss and obesity management market report are Novo Nordisk A/S, GlaxoSmithKline plc., F. Hoffmann-La Roche AG, Allergan Plc, Johnson & Johnson Services, Inc, Medtronic plc., Vivus Inc., Eisai Co., Ltd., ReShape Lifesciences, Inc, Obalon Therapeutics, Aspire Bariatrics, Allurion Technologies Inc., Nalpropion Pharmaceuticals, Inc., Beijing Noble Laser Technology Co., Ltd, and others.

Chapter 19 – Assumptions and Acronyms

This chapter includes a list of acronyms and assumptions that provide a base to the information and statistics included in the report.

Chapter 20 – Assumptions and Acronyms

This chapter helps readers understand the research methodology followed to obtain various conclusions and important qualitative information & quantitative information about the weight loss and obesity management market.

Weight Loss And Obesity Management Market Reports - Table of Contents

Get in touch

Harish Tiwari

Harish Tiwari

Global Head - Business Development

Pranay Mhaisekar

Pranay Mhaisekar

Business Development

* indicates mandatory fields.

Our Clients


CASE STUDIES

See how our work makes an impact.

At FMI, we design strategies that are adaptive, impactful, and implementable.

Request Sample Ask An Analyst Request Special Price Request Methodology